Your browser doesn't support javascript.
loading
Subcutaneous sarilumab for the treatment of hospitalized patients with moderate to severe COVID19 disease: A pragmatic, embedded randomized clinical trial.
Branch-Elliman, Westyn; Ferguson, Ryan; Doros, Gheorghe; Woods, Patricia; Leatherman, Sarah; Strymish, Judith; Datta, Rupak; Goswami, Rekha; Jankowich, Matthew D; Shah, Nishant R; Taylor, Thomas H; Page, Sarah T; Schiller, Sara J; Shannon, Colleen; Hau, Cynthia; Flynn, Maura; Holmberg, Erika; Visnaw, Karen; Dhond, Rupali; Brophy, Mary; Monach, Paul A.
Afiliación
  • Branch-Elliman W; VA Boston Healthcare System, Boston, Massachusetts, United States of America.
  • Ferguson R; Harvard Medical School, Boston, Massachusetts, United States of America.
  • Doros G; VA Boston Healthcare System, Boston, Massachusetts, United States of America.
  • Woods P; Evans Department of Medicine, Section of General Internal Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America.
  • Leatherman S; VA Boston Healthcare System, Boston, Massachusetts, United States of America.
  • Strymish J; Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, United States of America.
  • Datta R; VA Boston Healthcare System, Boston, Massachusetts, United States of America.
  • Goswami R; VA Boston Healthcare System, Boston, Massachusetts, United States of America.
  • Jankowich MD; VA Boston Healthcare System, Boston, Massachusetts, United States of America.
  • Shah NR; Hospital Epidemiology and Infection Prevention Program, VA Connecticut Healthcare System, West Haven, Connecticut, United States of America.
  • Taylor TH; Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut, United States of America.
  • Page ST; Section of Infectious Diseases, VA Maine Healthcare System, Togus, Maine, United States of America.
  • Schiller SJ; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Providence VA Medical Center, Alpert Medical School of Brown University, Providence, Rhode Island, United States of America.
  • Shannon C; Division of Cardiology, Department of Medicine, Providence VA Medical Center, Alpert Medical School of Brown University, Providence, Rhode Island, United States of America.
  • Hau C; Infectious Diseases and Rheumatology, White River Jct. VA Medical Center, Hartford, Vermont, United States of America.
  • Flynn M; VA Boston Healthcare System, Boston, Massachusetts, United States of America.
  • Holmberg E; VA Boston Healthcare System, Boston, Massachusetts, United States of America.
  • Visnaw K; VA Boston Healthcare System, Boston, Massachusetts, United States of America.
  • Dhond R; VA Boston Healthcare System, Boston, Massachusetts, United States of America.
  • Brophy M; VA Boston Healthcare System, Boston, Massachusetts, United States of America.
  • Monach PA; VA Boston Healthcare System, Boston, Massachusetts, United States of America.
PLoS One ; 17(2): e0263591, 2022.
Article en En | MEDLINE | ID: mdl-35213547
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Antivirales / Anticuerpos Monoclonales Humanizados / Tratamiento Farmacológico de COVID-19 / Antiinflamatorios Tipo de estudio: Clinical_trials Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Antivirales / Anticuerpos Monoclonales Humanizados / Tratamiento Farmacológico de COVID-19 / Antiinflamatorios Tipo de estudio: Clinical_trials Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos